{"ticker": "VXRT", "overview": {"cik": "72444", "ticker": "VXRT", "name": "Vaxart, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}]}, "description": "Vaxart, Inc. trades as VXRT and is registered in the United States, classified under Biological Products, (No Diagnostic Substances) (SIC 2836). Privy Trades holds 162 insider filings for the company, from June 2018 to May 2026. Across those, 13 insiders disclosed 18 open-market purchases totalling $3.06M against 20 sales totalling $318.41M. The most recent filing on record is dated 16 October 2026.", "exchange": null, "stats": {"buy_n": 18, "buy_sum": 3059226.3660000004, "sell_n": 20, "sell_sum": 318413002.6996, "net": -315353776.3336, "insiders": 13, "first_date": "2018-06-05", "last_date": "2026-05-22"}, "metrics": {"ticker": "VXRT", "has_prices": false}, "trades": [{"id": "0001437749-26-033037", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Raquel C. Bono", "who_key": "Bono Raquel C.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1823759/000143774926033037/0001437749-26-033037-index.htm", "trade_date": "2026-10-16", "timestamp": "2026-10-16", "mins": 25366}, {"id": "0001437749-26-023863", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Kevin Finney", "who_key": "Finney Kevin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926023863/0001437749-26-023863-index.htm", "trade_date": "2026-07-16", "timestamp": "2026-07-16", "mins": 157846}, {"id": "0001437749-26-023807", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "David E. Wheadon", "who_key": "Wheadon David E.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926023807/0001437749-26-023807-index.htm", "trade_date": "2026-07-16", "timestamp": "2026-07-16", "mins": 157846}, {"id": "0001437749-26-023808", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926023808/0001437749-26-023808-index.htm", "trade_date": "2026-07-16", "timestamp": "2026-07-16", "mins": 157846}, {"id": "0001437749-26-023809", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Elaine J. Heron", "who_key": "HERON ELAINE J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926023809/0001437749-26-023809-index.htm", "trade_date": "2026-07-16", "timestamp": "2026-07-16", "mins": 157846}, {"id": "0001437749-26-023810", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James B. Breitmeyer", "who_key": "BREITMEYER JAMES B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926023810/0001437749-26-023810-index.htm", "trade_date": "2026-07-16", "timestamp": "2026-07-16", "mins": 157846}, {"id": "0001437749-26-018385", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 6530.0, "score": 26.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director buys $7K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926018385/0001437749-26-018385-index.htm", "trade_date": "2026-05-22", "timestamp": "2026-05-22", "mins": 237046}, {"id": "0001437749-26-018117", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Jeroen Nicolaas Grasman", "who_key": "Grasman Jeroen Nicolaas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 19150.95, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926018117/0001437749-26-018117-index.htm", "trade_date": "2026-05-19", "timestamp": "2026-05-19", "mins": 241366}, {"id": "0001437749-26-014528", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James B. Breitmeyer", "who_key": "BREITMEYER JAMES B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926014528/0001437749-26-014528-index.htm", "trade_date": "2026-04-23", "timestamp": "2026-04-23", "mins": 278806}, {"id": "0001437749-26-010707", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James F. Cummings", "who_key": "Cummings James F.", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 2139.8, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926010707/0001437749-26-010707-index.htm", "trade_date": "2026-03-28", "timestamp": "2026-03-28", "mins": 316246}, {"id": "0001437749-26-010709", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Sean Tucker", "who_key": "Tucker Sean", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 2550.6, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926010709/0001437749-26-010709-index.htm", "trade_date": "2026-03-28", "timestamp": "2026-03-28", "mins": 316246}, {"id": "0001437749-26-009966", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Sean Tucker", "who_key": "Tucker Sean", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 25274.091999999997, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009966/0001437749-26-009966-index.htm", "trade_date": "2026-03-24", "timestamp": "2026-03-24", "mins": 322006}, {"id": "0001437749-26-009967", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Steven Lo", "who_key": "Lo Steven", "role": "President, Chief Exec Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 87463.432, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "President files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009967/0001437749-26-009967-index.htm", "trade_date": "2026-03-24", "timestamp": "2026-03-24", "mins": 322006}, {"id": "0001437749-26-009968", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James F. Cummings", "who_key": "Cummings James F.", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 21202.394, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009968/0001437749-26-009968-index.htm", "trade_date": "2026-03-24", "timestamp": "2026-03-24", "mins": 322006}, {"id": "0001437749-26-009969", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Edward B. Berg", "who_key": "Berg Edward B", "role": "SVP, General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 25274.091999999997, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009969/0001437749-26-009969-index.htm", "trade_date": "2026-03-24", "timestamp": "2026-03-24", "mins": 322006}, {"id": "0001437749-26-009205", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Sean Tucker", "who_key": "Tucker Sean", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 5122.4912, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009205/0001437749-26-009205-index.htm", "trade_date": "2026-03-18", "timestamp": "2026-03-18", "mins": 330646}, {"id": "0001437749-26-009206", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Steven Lo", "who_key": "Lo Steven", "role": "President, Chief Exec Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 14230.905, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "President files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009206/0001437749-26-009206-index.htm", "trade_date": "2026-03-18", "timestamp": "2026-03-18", "mins": 330646}, {"id": "0001437749-26-009207", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James F. Cummings", "who_key": "Cummings James F.", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 4297.5112, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009207/0001437749-26-009207-index.htm", "trade_date": "2026-03-18", "timestamp": "2026-03-18", "mins": 330646}, {"id": "0001437749-26-009208", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Edward B. Berg", "who_key": "Berg Edward B", "role": "SVP, General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 5122.4912, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926009208/0001437749-26-009208-index.htm", "trade_date": "2026-03-18", "timestamp": "2026-03-18", "mins": 330646}, {"id": "0001437749-26-008906", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Edward B. Berg", "who_key": "Berg Edward B", "role": "SVP, General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926008906/0001437749-26-008906-index.htm", "trade_date": "2026-03-16", "timestamp": "2026-03-16", "mins": 333526}, {"id": "0001437749-26-008907", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James F. Cummings", "who_key": "Cummings James F.", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926008907/0001437749-26-008907-index.htm", "trade_date": "2026-03-16", "timestamp": "2026-03-16", "mins": 333526}, {"id": "0001437749-26-008908", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Jeroen Nicolaas Grasman", "who_key": "Grasman Jeroen Nicolaas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926008908/0001437749-26-008908-index.htm", "trade_date": "2026-03-16", "timestamp": "2026-03-16", "mins": 333526}, {"id": "0001437749-26-008909", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Sean Tucker", "who_key": "Tucker Sean", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926008909/0001437749-26-008909-index.htm", "trade_date": "2026-03-16", "timestamp": "2026-03-16", "mins": 333526}, {"id": "0001437749-26-008925", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Steven Lo", "who_key": "Lo Steven", "role": "President, Chief Exec Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "President files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926008925/0001437749-26-008925-index.htm", "trade_date": "2026-03-16", "timestamp": "2026-03-16", "mins": 333526}, {"id": "0001437749-26-003253", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Sean Tucker", "who_key": "Tucker Sean", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 5637.7525000000005, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926003253/0001437749-26-003253-index.htm", "trade_date": "2026-02-02", "timestamp": "2026-02-02", "mins": 394006}, {"id": "0001437749-26-003254", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Edward B. Berg", "who_key": "Berg Edward B", "role": "SVP, General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 5637.7525000000005, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926003254/0001437749-26-003254-index.htm", "trade_date": "2026-02-02", "timestamp": "2026-02-02", "mins": 394006}, {"id": "0001437749-26-003255", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "James F. Cummings", "who_key": "Cummings James F.", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 4846.7025, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926003255/0001437749-26-003255-index.htm", "trade_date": "2026-02-02", "timestamp": "2026-02-02", "mins": 394006}, {"id": "0001437749-25-037206", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Steven Lo", "who_key": "Lo Steven", "role": "President, Chief Exec Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 20036.61, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "President files routine paperwork on VXRT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925037206/0001437749-25-037206-index.htm", "trade_date": "2025-12-04", "timestamp": "2025-12-04", "mins": 480406}, {"id": "0001437749-25-035952", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Elaine J. Heron", "who_key": "HERON ELAINE J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15921.396, "score": 35.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $16K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925035952/0001437749-25-035952-index.htm", "trade_date": "2025-11-17", "timestamp": "2025-11-17", "mins": 504886}, {"id": "0001437749-25-037051", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8185.0, "score": 28.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board insider adds $8K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925037051/0001437749-25-037051-index.htm", "trade_date": "2025-11-17", "timestamp": "2025-11-17", "mins": 504886}], "recent_buys": [{"id": "0001437749-26-018385", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 6530.0, "score": 26.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director buys $7K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774926018385/0001437749-26-018385-index.htm", "trade_date": "2026-05-22", "timestamp": "2026-05-22", "mins": 237046}, {"id": "0001437749-25-037051", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8185.0, "score": 28.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board insider adds $8K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925037051/0001437749-25-037051-index.htm", "trade_date": "2025-11-17", "timestamp": "2025-11-17", "mins": 504886}, {"id": "0001437749-25-035952", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Elaine J. Heron", "who_key": "HERON ELAINE J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15921.396, "score": 35.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $16K of VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925035952/0001437749-25-035952-index.htm", "trade_date": "2025-11-17", "timestamp": "2025-11-17", "mins": 504886}, {"id": "0001437749-25-027356", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Kevin Finney", "who_key": "Finney Kevin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 61933.840000000004, "score": 44.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 3 insiders into VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925027356/0001437749-25-027356-index.htm", "trade_date": "2025-08-15", "timestamp": "2025-08-15", "mins": 640246}, {"id": "0001437749-25-024250", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 4050.0000000000005, "score": 25.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925024250/0001437749-25-024250-index.htm", "trade_date": "2025-07-29", "timestamp": "2025-07-29", "mins": 664726}, {"id": "0001437749-25-017678", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Steven Lo", "who_key": "Lo Steven", "role": "President, Chief Exec Officer, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 49000.0, "score": 40.4, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying VXRT \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925017678/0001437749-25-017678-index.htm", "trade_date": "2025-05-19", "timestamp": "2025-05-19", "mins": 766966}, {"id": "0001437749-24-020694", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 13577.999999999998, "score": 34.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 5 buying VXRT", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774924020694/0001437749-24-020694-index.htm", "trade_date": "2024-06-18", "timestamp": "2024-06-18", "mins": 1249366}, {"id": "0001437749-22-029843", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "W. Mark Watson", "who_key": "Watson W. Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15140.0, "score": 29.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "VXRT draws its 5th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774922029843/0001437749-22-029843-index.htm", "trade_date": "2022-12-28", "timestamp": "2022-12-28", "mins": 2024086}, {"id": "0001437749-22-015757", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Fuad Ahmad", "who_key": "Ahmad Fuad", "role": "Interim CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 16100.000000000002, "score": 37.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying VXRT \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774922015757/0001437749-22-015757-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0000919574-19-006771", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Armistice Capital, LLC", "who_key": "ARMISTICE CAPITAL, LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 67256.18000000001, "score": 37.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying VXRT \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006771/0000919574-19-006771-index.htm", "trade_date": "2019-11-07", "timestamp": "2019-11-07", "mins": 3675766}, {"id": "0001437749-19-020035", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "John P. Richard", "who_key": "Richard John P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 7680.0, "score": 26.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "VXRT draws its 7th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774919020035/0001437749-19-020035-index.htm", "trade_date": "2019-10-11", "timestamp": "2019-10-11", "mins": 3714646}, {"id": "0000919574-19-006268", "src": "INSIDERS", "ticker": "VXRT", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Vaxart, Inc.", "who": "Armistice Capital, LLC", "who_key": "ARMISTICE CAPITAL, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 203200.0, "score": 40.4, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying VXRT \u2014 8 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006268/0000919574-19-006268-index.htm", "trade_date": "2019-10-07", "timestamp": "2019-10-07", "mins": 3720406}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "Merged (2025)", "items": [{"action": "DELISTED", "reason": "MERGED", "counterparty": null, "old_value": "VXRT", "new_value": "Merged", "effective": "2025-11-21", "evidence": "Form 25-NSE filed 2025-11-21, following a merger filing on 2018-02-09", "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000072444", "applied": 1, "detected_at": "2026-08-03T11:20:33.158960"}, {"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "VXRT", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.877154"}]}, "key_people": [{"who": "Armistice Capital, LLC", "who_key": "ARMISTICE CAPITAL, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 2564086.58, "sold": 313194495.90000004, "net": -310630409.32000005, "trades": 12, "top_score": 56.8, "lean": "selling", "history": [{"action": "SELL", "amount": 266997653.4, "date": "2020-06-29", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420004394/0000919574-20-004394-index.htm"}, {"action": "SELL", "amount": 3856000.0, "date": "2020-06-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003930/0000919574-20-003930-index.htm"}, {"action": "SELL", "amount": 522000.0, "date": "2020-05-27", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003890/0000919574-20-003890-index.htm"}, {"action": "SELL", "amount": 5428500.0, "date": "2020-05-22", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003812/0000919574-20-003812-index.htm"}, {"action": "SELL", "amount": 5673062.359999999, "date": "2020-05-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003756/0000919574-20-003756-index.htm"}, {"action": "SELL", "amount": 9962929.040000001, "date": "2020-05-13", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003296/0000919574-20-003296-index.htm"}, {"action": "SELL", "amount": 632000.0, "date": "2020-05-08", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003215/0000919574-20-003215-index.htm"}, {"action": "SELL", "amount": 20122351.1, "date": "2020-04-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420003105/0000919574-20-003105-index.htm"}, {"action": "BUY", "amount": 67256.18000000001, "date": "2019-11-07", "score": 37.1, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006771/0000919574-19-006771-index.htm"}, {"action": "BUY", "amount": 203200.0, "date": "2019-10-07", "score": 40.4, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006268/0000919574-19-006268-index.htm"}, {"action": "BUY", "amount": 150551.93, "date": "2019-10-03", "score": 38.8, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006208/0000919574-19-006208-index.htm"}, {"action": "BUY", "amount": 2143078.47, "date": "2019-09-30", "score": 56.8, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957419006126/0000919574-19-006126-index.htm"}], "latest": {"action": "SELL", "amount": 266997653.4, "date": "2020-06-29", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000091957420004394/0000919574-20-004394-index.htm"}}, {"who": "Wouter Latour", "who_key": "Latour Wouter", "role": "President and Chief Executive, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 50000.1, "sold": 4381227.5496, "net": -4331227.4496, "trades": 4, "top_score": 45.5, "lean": "selling", "history": [{"action": "SELL", "amount": 1366640.0, "date": "2021-05-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921011553/0001437749-21-011553-index.htm"}, {"action": "SELL", "amount": 906450.0, "date": "2021-03-04", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921005145/0001437749-21-005145-index.htm"}, {"action": "SELL", "amount": 2108137.5496, "date": "2020-11-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774920024358/0001437749-20-024358-index.htm"}, {"action": "BUY", "amount": 50000.1, "date": "2019-09-30", "score": 45.5, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774919019280/0001437749-19-019280-index.htm"}], "latest": {"action": "SELL", "amount": 1366640.0, "date": "2021-05-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921011553/0001437749-21-011553-index.htm"}}, {"who": "Margaret Echerd", "who_key": "Echerd Margaret", "role": "SVP, Principal Accntng Officer", "person_type": "EXEC", "person_label": "Execs", "bought": 0, "sold": 443655.1, "net": -443655.1, "trades": 5, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 16389.1, "date": "2021-09-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921022057/0001437749-21-022057-index.htm"}, {"action": "SELL", "amount": 18010.0, "date": "2021-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921019514/0001437749-21-019514-index.htm"}, {"action": "SELL", "amount": 14400.0, "date": "2021-07-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921017301/0001437749-21-017301-index.htm"}, {"action": "SELL", "amount": 14416.0, "date": "2021-06-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921014725/0001437749-21-014725-index.htm"}, {"action": "SELL", "amount": 380440.0, "date": "2021-06-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921014606/0001437749-21-014606-index.htm"}], "latest": {"action": "SELL", "amount": 16389.1, "date": "2021-09-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921022057/0001437749-21-022057-index.htm"}}, {"who": "Michael J. Finney", "who_key": "Finney Michael J.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 217021.15000000002, "sold": 0, "net": 217021.15000000002, "trades": 2, "top_score": 52.7, "lean": "buying", "history": [{"action": "BUY", "amount": 199999.80000000002, "date": "2019-04-11", "score": 52.7, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774919007107/0001437749-19-007107-index.htm"}, {"action": "BUY", "amount": 17021.35, "date": "2018-06-05", "score": 30.2, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919118036746/0001209191-18-036746-index.htm"}], "latest": {"action": "BUY", "amount": 199999.80000000002, "date": "2019-04-11", "score": 52.7, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774919007107/0001437749-19-007107-index.htm"}}, {"who": "Todd C. Davis", "who_key": "Davis Todd C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 196500.0, "net": -196500.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 196500.0, "date": "2020-04-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774920009007/0001437749-20-009007-index.htm"}], "latest": {"action": "SELL", "amount": 196500.0, "date": "2020-04-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774920009007/0001437749-20-009007-index.htm"}}, {"who": "Sean Tucker", "who_key": "Tucker Sean", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 30000.300000000003, "sold": 102000.0, "net": -71999.7, "trades": 2, "top_score": 51.6, "lean": "selling", "history": [{"action": "SELL", "amount": 102000.0, "date": "2021-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921019515/0001437749-21-019515-index.htm"}, {"action": "BUY", "amount": 30000.300000000003, "date": "2019-04-11", "score": 51.6, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774919007119/0001437749-19-007119-index.htm"}], "latest": {"action": "SELL", "amount": 102000.0, "date": "2021-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921019515/0001437749-21-019515-index.htm"}}, {"who": "Robert A. Yedid", "who_key": "Yedid Robert A.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 95124.15000000002, "net": -95124.15000000002, "trades": 2, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 9015.150000000001, "date": "2022-01-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774922023849/0001437749-22-023849-index.htm"}, {"action": "SELL", "amount": 86109.00000000001, "date": "2021-06-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774921014727/0001437749-21-014727-index.htm"}], "latest": {"action": "SELL", "amount": 9015.150000000001, "date": "2022-01-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774922023849/0001437749-22-023849-index.htm"}}, {"who": "Kevin Finney", "who_key": "Finney Kevin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 61933.840000000004, "sold": 0, "net": 61933.840000000004, "trades": 1, "top_score": 44.3, "lean": "buying", "history": [{"action": "BUY", "amount": 61933.840000000004, "date": "2025-08-15", "score": 44.3, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925027356/0001437749-25-027356-index.htm"}], "latest": {"action": "BUY", "amount": 61933.840000000004, "date": "2025-08-15", "score": 44.3, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774925027356/0001437749-25-027356-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}], "performance": {"ticker": "VXRT", "has_prices": false, "summary": null, "buys": [{"who": "Watson W. Mark", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 6530.0, "date": "2026-05-22", "score": 26.7, "ref_price": null, "return": null}, {"who": "Watson W. Mark", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8185.0, "date": "2025-11-17", "score": 28.7, "ref_price": null, "return": null}, {"who": "HERON ELAINE J", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15921.396, "date": "2025-11-17", "score": 35.9, "ref_price": null, "return": null}, {"who": "Finney Kevin", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 61933.840000000004, "date": "2025-08-15", "score": 44.3, "ref_price": null, "return": null}, {"who": "Watson W. Mark", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 4050.0000000000005, "date": "2025-07-29", "score": 25.0, "ref_price": null, "return": null}, {"who": "Lo Steven", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "President, Chief Exec Officer, Director", "amount": 49000.0, "date": "2025-05-19", "score": 40.4, "ref_price": null, "return": null}, {"who": "Watson W. Mark", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 13577.999999999998, "date": "2024-06-18", "score": 34.1, "ref_price": null, "return": null}, {"who": "Watson W. Mark", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15140.0, "date": "2022-12-28", "score": 29.5, "ref_price": null, "return": null}, {"who": "Ahmad Fuad", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Interim CFO", "amount": 16100.000000000002, "date": "2022-06-22", "score": 37.3, "ref_price": null, "return": null}, {"who": "ARMISTICE CAPITAL, LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 67256.18000000001, "date": "2019-11-07", "score": 37.1, "ref_price": null, "return": null}, {"who": "Richard John P", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 7680.0, "date": "2019-10-11", "score": 26.3, "ref_price": null, "return": null}, {"who": "ARMISTICE CAPITAL, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 203200.0, "date": "2019-10-07", "score": 40.4, "ref_price": null, "return": null}, {"who": "ARMISTICE CAPITAL, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 150551.93, "date": "2019-10-03", "score": 38.8, "ref_price": null, "return": null}, {"who": "ARMISTICE CAPITAL, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2143078.47, "date": "2019-09-30", "score": 56.8, "ref_price": null, "return": null}, {"who": "Latour Wouter", "person_type": "CEO", "person_label": "CEOs", "role": "President and Chief Executive, Director", "amount": 50000.1, "date": "2019-09-30", "score": 45.5, "ref_price": null, "return": null}, {"who": "Tucker Sean", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Scientific Officer", "amount": 30000.300000000003, "date": "2019-04-11", "score": 51.6, "ref_price": null, "return": null}, {"who": "Finney Michael J.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 199999.80000000002, "date": "2019-04-11", "score": 52.7, "ref_price": null, "return": null}, {"who": "Finney Michael J.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 17021.35, "date": "2018-06-05", "score": 30.2, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}